Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitrectomy | 65 | 2024 | 365 | 12.730 |
Why?
|
Retinal Detachment | 55 | 2023 | 411 | 11.140 |
Why?
|
Endophthalmitis | 24 | 2024 | 263 | 6.820 |
Why?
|
Visual Acuity | 86 | 2024 | 2520 | 6.010 |
Why?
|
Retinal Perforations | 26 | 2022 | 131 | 5.860 |
Why?
|
Eye Injuries, Penetrating | 12 | 2024 | 115 | 4.580 |
Why?
|
Retinal Diseases | 19 | 2023 | 683 | 3.890 |
Why?
|
Vitreous Body | 18 | 2022 | 389 | 3.680 |
Why?
|
Epiretinal Membrane | 14 | 2023 | 68 | 3.540 |
Why?
|
Vitreoretinopathy, Proliferative | 10 | 2023 | 68 | 3.280 |
Why?
|
Scleral Buckling | 18 | 2023 | 84 | 2.680 |
Why?
|
Diabetic Retinopathy | 25 | 2023 | 1205 | 2.640 |
Why?
|
Fluorescein Angiography | 34 | 2023 | 936 | 2.590 |
Why?
|
Eye Foreign Bodies | 8 | 2024 | 55 | 2.490 |
Why?
|
Intravitreal Injections | 24 | 2023 | 345 | 2.480 |
Why?
|
Macular Edema | 16 | 2023 | 359 | 2.480 |
Why?
|
Tomography, Optical Coherence | 48 | 2023 | 2637 | 2.350 |
Why?
|
Eye Infections, Fungal | 5 | 2018 | 110 | 2.290 |
Why?
|
Retina | 30 | 2023 | 2611 | 2.270 |
Why?
|
Retinal Pigment Epithelium | 9 | 2017 | 302 | 2.250 |
Why?
|
Choroid | 8 | 2019 | 317 | 2.150 |
Why?
|
Choroid Diseases | 7 | 2016 | 66 | 2.110 |
Why?
|
Vitreous Hemorrhage | 6 | 2024 | 48 | 2.020 |
Why?
|
Eye Infections, Bacterial | 8 | 2022 | 235 | 1.950 |
Why?
|
Retinal Vein Occlusion | 9 | 2018 | 137 | 1.870 |
Why?
|
Angiogenesis Inhibitors | 19 | 2023 | 2038 | 1.650 |
Why?
|
Eye Injuries | 8 | 2019 | 245 | 1.630 |
Why?
|
Ophthalmologic Surgical Procedures | 5 | 2018 | 349 | 1.600 |
Why?
|
Retinal Hemorrhage | 7 | 2020 | 96 | 1.530 |
Why?
|
Endotamponade | 8 | 2021 | 35 | 1.460 |
Why?
|
Subretinal Fluid | 2 | 2019 | 24 | 1.310 |
Why?
|
Vitreoretinal Surgery | 5 | 2021 | 27 | 1.190 |
Why?
|
Laser Coagulation | 8 | 2020 | 326 | 1.180 |
Why?
|
Central Serous Chorioretinopathy | 2 | 2017 | 27 | 1.170 |
Why?
|
Eye Diseases | 5 | 2017 | 670 | 1.170 |
Why?
|
Macular Degeneration | 10 | 2022 | 980 | 1.130 |
Why?
|
Basement Membrane | 7 | 2020 | 356 | 1.070 |
Why?
|
Silicone Oils | 4 | 2021 | 22 | 1.070 |
Why?
|
Retinal Vasculitis | 5 | 2017 | 42 | 1.030 |
Why?
|
Iodine | 2 | 2017 | 285 | 0.990 |
Why?
|
Vascular Endothelial Growth Factor A | 19 | 2023 | 3502 | 0.940 |
Why?
|
Retinal Vessels | 11 | 2023 | 769 | 0.930 |
Why?
|
Optic Nerve Diseases | 2 | 2017 | 327 | 0.880 |
Why?
|
Macula Lutea | 4 | 2023 | 151 | 0.870 |
Why?
|
Fluorocarbons | 7 | 2018 | 452 | 0.850 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2022 | 21 | 0.840 |
Why?
|
Vision, Monocular | 1 | 2022 | 78 | 0.810 |
Why?
|
Postoperative Complications | 15 | 2022 | 15244 | 0.760 |
Why?
|
Vision Disorders | 7 | 2022 | 1057 | 0.760 |
Why?
|
Vision, Binocular | 1 | 2022 | 213 | 0.750 |
Why?
|
Fundus Oculi | 15 | 2020 | 472 | 0.710 |
Why?
|
Cataract Extraction | 6 | 2022 | 482 | 0.710 |
Why?
|
Optic Disk | 3 | 2020 | 401 | 0.700 |
Why?
|
Humans | 198 | 2024 | 742088 | 0.680 |
Why?
|
Indicators and Reagents | 1 | 2020 | 462 | 0.670 |
Why?
|
Electric Injuries | 1 | 2018 | 26 | 0.660 |
Why?
|
Myopia, Degenerative | 1 | 2018 | 15 | 0.660 |
Why?
|
Aicardi Syndrome | 1 | 2018 | 17 | 0.660 |
Why?
|
Choroid Hemorrhage | 2 | 2017 | 6 | 0.640 |
Why?
|
Surgical Wound Infection | 3 | 2017 | 1538 | 0.640 |
Why?
|
Fibrinolysin | 2 | 2015 | 131 | 0.630 |
Why?
|
Drug Compounding | 1 | 2019 | 242 | 0.630 |
Why?
|
Pseudallescheria | 1 | 2017 | 3 | 0.630 |
Why?
|
Sclera | 3 | 2017 | 200 | 0.620 |
Why?
|
Blast Injuries | 3 | 2024 | 302 | 0.620 |
Why?
|
Hypersensitivity | 2 | 2017 | 1093 | 0.620 |
Why?
|
Coloring Agents | 2 | 2020 | 565 | 0.620 |
Why?
|
Filtering Surgery | 1 | 2017 | 35 | 0.610 |
Why?
|
Glaucoma | 5 | 2022 | 1152 | 0.610 |
Why?
|
Lighting | 1 | 2020 | 231 | 0.600 |
Why?
|
Choroidal Neovascularization | 3 | 2016 | 343 | 0.600 |
Why?
|
Middle Aged | 93 | 2023 | 213127 | 0.580 |
Why?
|
Hypertensive Retinopathy | 1 | 2016 | 4 | 0.570 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2217 | 0.560 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 45 | 0.560 |
Why?
|
Retrospective Studies | 60 | 2024 | 77098 | 0.560 |
Why?
|
Endothelium, Corneal | 1 | 2018 | 147 | 0.560 |
Why?
|
Povidone-Iodine | 1 | 2016 | 59 | 0.560 |
Why?
|
Vancomycin | 3 | 2017 | 500 | 0.550 |
Why?
|
Drug Users | 1 | 2017 | 131 | 0.540 |
Why?
|
Retinal Neurons | 2 | 2014 | 65 | 0.530 |
Why?
|
Leukostasis | 1 | 2015 | 22 | 0.530 |
Why?
|
Angiomatosis | 1 | 2015 | 49 | 0.530 |
Why?
|
Anti-Bacterial Agents | 11 | 2022 | 7153 | 0.520 |
Why?
|
Retinal Dystrophies | 1 | 2016 | 58 | 0.520 |
Why?
|
Male | 109 | 2023 | 349538 | 0.520 |
Why?
|
Geographic Atrophy | 1 | 2016 | 66 | 0.520 |
Why?
|
Cornea | 5 | 2022 | 1497 | 0.520 |
Why?
|
Giant Cell Arteritis | 2 | 2016 | 292 | 0.510 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 51 | 0.500 |
Why?
|
Retinal Artery Occlusion | 3 | 2013 | 74 | 0.500 |
Why?
|
Temporal Arteries | 1 | 2015 | 128 | 0.490 |
Why?
|
Polyps | 1 | 2016 | 189 | 0.490 |
Why?
|
Retinal Neovascularization | 7 | 2021 | 244 | 0.490 |
Why?
|
Infarction | 1 | 2015 | 243 | 0.480 |
Why?
|
Prostheses and Implants | 5 | 2022 | 1385 | 0.480 |
Why?
|
Leukocytosis | 1 | 2015 | 247 | 0.470 |
Why?
|
Fibrin | 1 | 2016 | 506 | 0.470 |
Why?
|
Syphilis | 1 | 2016 | 226 | 0.470 |
Why?
|
Glucocorticoids | 7 | 2018 | 2107 | 0.470 |
Why?
|
Connective Tissue Growth Factor | 2 | 2019 | 96 | 0.470 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2013 | 45 | 0.460 |
Why?
|
Uveal Diseases | 1 | 2013 | 45 | 0.450 |
Why?
|
Ophthalmology | 2 | 2017 | 506 | 0.450 |
Why?
|
Spironolactone | 1 | 2016 | 382 | 0.450 |
Why?
|
Retinoschisis | 2 | 2023 | 30 | 0.450 |
Why?
|
Basketball | 1 | 2013 | 49 | 0.440 |
Why?
|
Blindness | 6 | 2016 | 615 | 0.430 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 638 | 0.420 |
Why?
|
Corpus Striatum | 1 | 2018 | 1220 | 0.420 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2022 | 664 | 0.410 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 315 | 0.410 |
Why?
|
Staphylococcal Infections | 2 | 2016 | 1398 | 0.410 |
Why?
|
Exanthema | 1 | 2016 | 488 | 0.400 |
Why?
|
Fluocinolone Acetonide | 1 | 2011 | 36 | 0.400 |
Why?
|
Air Bags | 1 | 2011 | 13 | 0.400 |
Why?
|
Female | 102 | 2023 | 379592 | 0.400 |
Why?
|
Anterior Chamber | 3 | 1998 | 195 | 0.400 |
Why?
|
Tissue Plasminogen Activator | 1 | 2018 | 1262 | 0.400 |
Why?
|
Aged | 65 | 2023 | 162944 | 0.390 |
Why?
|
Firearms | 1 | 2018 | 597 | 0.390 |
Why?
|
Aniridia | 1 | 2010 | 36 | 0.380 |
Why?
|
Aphakia | 1 | 2010 | 24 | 0.380 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1071 | 0.380 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1188 | 0.380 |
Why?
|
Pseudophakia | 2 | 2021 | 62 | 0.380 |
Why?
|
Disease Management | 2 | 2020 | 2450 | 0.380 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 689 | 0.370 |
Why?
|
Bacteria | 2 | 2018 | 2102 | 0.360 |
Why?
|
Anterior Eye Segment | 2 | 2010 | 153 | 0.360 |
Why?
|
Follow-Up Studies | 31 | 2022 | 39004 | 0.360 |
Why?
|
Adult | 60 | 2023 | 213712 | 0.360 |
Why?
|
Bioprosthesis | 1 | 2014 | 596 | 0.360 |
Why?
|
Klebsiella Infections | 1 | 2011 | 137 | 0.350 |
Why?
|
Choroid Neoplasms | 1 | 2011 | 175 | 0.350 |
Why?
|
Visual Prosthesis | 3 | 2016 | 52 | 0.350 |
Why?
|
Iris | 1 | 2010 | 239 | 0.350 |
Why?
|
Polymers | 1 | 2017 | 1618 | 0.350 |
Why?
|
Melanocytes | 1 | 2013 | 515 | 0.350 |
Why?
|
Klebsiella pneumoniae | 1 | 2011 | 246 | 0.340 |
Why?
|
Risk Assessment | 4 | 2021 | 23320 | 0.330 |
Why?
|
Corneal Diseases | 3 | 2022 | 615 | 0.330 |
Why?
|
Sutures | 1 | 2010 | 298 | 0.320 |
Why?
|
Trabeculectomy | 2 | 2015 | 162 | 0.320 |
Why?
|
Metals | 1 | 2013 | 717 | 0.320 |
Why?
|
Lens Implantation, Intraocular | 4 | 2017 | 193 | 0.320 |
Why?
|
Fibrinolytic Agents | 2 | 2015 | 2156 | 0.320 |
Why?
|
Intraocular Pressure | 8 | 2020 | 1274 | 0.310 |
Why?
|
Fungi | 2 | 2018 | 327 | 0.310 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 883 | 0.300 |
Why?
|
Cataract | 3 | 2022 | 833 | 0.300 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1618 | 0.290 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2020 | 345 | 0.290 |
Why?
|
Drug Implants | 3 | 2018 | 243 | 0.290 |
Why?
|
Skin Diseases | 1 | 2015 | 1065 | 0.280 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1331 | 0.280 |
Why?
|
Microscopy, Acoustic | 2 | 2019 | 45 | 0.270 |
Why?
|
Suture Techniques | 2 | 2010 | 797 | 0.270 |
Why?
|
Recombinant Fusion Proteins | 4 | 2022 | 3770 | 0.260 |
Why?
|
Peptide Fragments | 2 | 2015 | 5095 | 0.260 |
Why?
|
Recurrence | 5 | 2019 | 8333 | 0.260 |
Why?
|
Accidents, Traffic | 1 | 2011 | 819 | 0.260 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6347 | 0.250 |
Why?
|
Urban Population | 1 | 2013 | 2018 | 0.250 |
Why?
|
Wounds, Nonpenetrating | 1 | 2011 | 794 | 0.240 |
Why?
|
Aged, 80 and over | 22 | 2023 | 57683 | 0.240 |
Why?
|
Self Mutilation | 1 | 2004 | 58 | 0.240 |
Why?
|
Foreign-Body Migration | 2 | 1998 | 221 | 0.230 |
Why?
|
Fovea Centralis | 2 | 2023 | 118 | 0.230 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2023 | 185 | 0.230 |
Why?
|
Exudates and Transudates | 3 | 2016 | 171 | 0.230 |
Why?
|
Treatment Outcome | 29 | 2023 | 62966 | 0.230 |
Why?
|
Trauma Severity Indices | 2 | 2017 | 481 | 0.230 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1351 | 0.230 |
Why?
|
Retinitis Pigmentosa | 3 | 2016 | 386 | 0.230 |
Why?
|
Antibodies, Monoclonal | 3 | 2010 | 9274 | 0.230 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2023 | 19 | 0.220 |
Why?
|
Osteogenesis Imperfecta | 1 | 2003 | 83 | 0.220 |
Why?
|
Aqueous Humor | 4 | 2013 | 161 | 0.210 |
Why?
|
Intraoperative Period | 2 | 2021 | 520 | 0.210 |
Why?
|
Choroideremia | 1 | 2022 | 25 | 0.210 |
Why?
|
Injections | 4 | 2017 | 840 | 0.210 |
Why?
|
Eye Infections, Viral | 2 | 2020 | 57 | 0.210 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1527 | 0.210 |
Why?
|
Eisenmenger Complex | 1 | 2001 | 27 | 0.200 |
Why?
|
Candida | 1 | 2002 | 172 | 0.200 |
Why?
|
Bacteremia | 2 | 2023 | 962 | 0.200 |
Why?
|
Self Report | 3 | 2017 | 3548 | 0.200 |
Why?
|
Tourette Syndrome | 1 | 2004 | 379 | 0.200 |
Why?
|
Retinal Degeneration | 2 | 2018 | 414 | 0.200 |
Why?
|
Risk Factors | 13 | 2024 | 72145 | 0.200 |
Why?
|
Adolescent | 18 | 2020 | 85649 | 0.190 |
Why?
|
Prednisolone | 4 | 2015 | 333 | 0.190 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1581 | 0.190 |
Why?
|
Staphylococcus | 2 | 2016 | 155 | 0.190 |
Why?
|
Emulsions | 2 | 2020 | 155 | 0.190 |
Why?
|
Young Adult | 13 | 2022 | 56350 | 0.180 |
Why?
|
Coxsackievirus Infections | 1 | 2020 | 44 | 0.180 |
Why?
|
Ophthalmoscopy | 2 | 2019 | 176 | 0.180 |
Why?
|
Smoking | 1 | 2017 | 8969 | 0.180 |
Why?
|
Enterovirus | 1 | 2020 | 64 | 0.180 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 31 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7901 | 0.180 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2022 | 341 | 0.170 |
Why?
|
Myopia | 1 | 2021 | 254 | 0.160 |
Why?
|
Administration, Oral | 3 | 2016 | 3913 | 0.160 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2018 | 79 | 0.160 |
Why?
|
Quinoxalines | 1 | 2020 | 288 | 0.160 |
Why?
|
Contact Lenses | 1 | 2020 | 145 | 0.160 |
Why?
|
Retinal Telangiectasis | 1 | 2018 | 24 | 0.160 |
Why?
|
Silicone Elastomers | 2 | 1999 | 84 | 0.160 |
Why?
|
Postoperative Period | 2 | 2020 | 1839 | 0.160 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3507 | 0.160 |
Why?
|
Haemophilus Infections | 1 | 1998 | 95 | 0.160 |
Why?
|
Coloboma | 1 | 2018 | 54 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2002 | 522 | 0.150 |
Why?
|
Haemophilus influenzae | 1 | 1998 | 171 | 0.150 |
Why?
|
Prospective Studies | 19 | 2022 | 53187 | 0.150 |
Why?
|
Incidence | 6 | 2021 | 20928 | 0.150 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5724 | 0.150 |
Why?
|
Ultrasonography | 4 | 2019 | 5978 | 0.150 |
Why?
|
Time Factors | 9 | 2021 | 40054 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 7 | 2019 | 20086 | 0.140 |
Why?
|
Drug Therapy, Combination | 7 | 2015 | 6483 | 0.140 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 35 | 0.140 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 117 | 0.140 |
Why?
|
Laser Therapy | 2 | 2020 | 1071 | 0.140 |
Why?
|
Pigment Epithelium of Eye | 2 | 1997 | 220 | 0.140 |
Why?
|
Phacoemulsification | 2 | 1997 | 149 | 0.140 |
Why?
|
European Union | 1 | 2017 | 157 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2019 | 21719 | 0.140 |
Why?
|
Adrenergic beta-Agonists | 1 | 1997 | 346 | 0.140 |
Why?
|
Fusarium | 2 | 2006 | 51 | 0.140 |
Why?
|
Ocular Hypertension | 3 | 2002 | 197 | 0.130 |
Why?
|
Retinal Drusen | 1 | 2016 | 66 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 713 | 0.130 |
Why?
|
Liposomes | 1 | 2019 | 758 | 0.130 |
Why?
|
Visually Impaired Persons | 1 | 2016 | 81 | 0.130 |
Why?
|
Phospholipids | 1 | 2019 | 781 | 0.130 |
Why?
|
Massachusetts | 3 | 2017 | 8662 | 0.130 |
Why?
|
Glaucoma, Neovascular | 1 | 2015 | 33 | 0.130 |
Why?
|
Moraxellaceae Infections | 1 | 2015 | 8 | 0.130 |
Why?
|
Methotrexate | 2 | 2023 | 1720 | 0.130 |
Why?
|
Prosthesis Implantation | 2 | 2022 | 641 | 0.130 |
Why?
|
Prognosis | 9 | 2021 | 29010 | 0.130 |
Why?
|
Microsurgery | 2 | 2011 | 796 | 0.130 |
Why?
|
Collagen Diseases | 1 | 2015 | 34 | 0.130 |
Why?
|
Device Approval | 1 | 2017 | 163 | 0.130 |
Why?
|
Military Personnel | 1 | 2024 | 1132 | 0.130 |
Why?
|
Atrophy | 3 | 2023 | 1576 | 0.130 |
Why?
|
Vitreous Detachment | 1 | 2015 | 22 | 0.130 |
Why?
|
Double-Blind Method | 3 | 2015 | 12017 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35342 | 0.120 |
Why?
|
New England | 1 | 2017 | 1021 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8621 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 12958 | 0.120 |
Why?
|
Aptamers, Nucleotide | 1 | 2015 | 166 | 0.120 |
Why?
|
Drug Substitution | 2 | 2015 | 281 | 0.120 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 230 | 0.120 |
Why?
|
Haiti | 1 | 2016 | 551 | 0.120 |
Why?
|
Organ Size | 1 | 2019 | 2253 | 0.120 |
Why?
|
Child, Preschool | 7 | 2019 | 40955 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1533 | 0.120 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 58 | 0.110 |
Why?
|
Optic Atrophies, Hereditary | 1 | 1993 | 27 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 215 | 0.110 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6171 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3336 | 0.110 |
Why?
|
Vision, Low | 1 | 2015 | 168 | 0.110 |
Why?
|
Lenses, Intraocular | 4 | 1999 | 142 | 0.110 |
Why?
|
Sclerostomy | 3 | 2012 | 15 | 0.110 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2015 | 625 | 0.110 |
Why?
|
Uveitis | 1 | 2016 | 375 | 0.110 |
Why?
|
Mycoses | 2 | 2006 | 376 | 0.110 |
Why?
|
HIV Seronegativity | 1 | 2013 | 211 | 0.110 |
Why?
|
Explosions | 1 | 2013 | 109 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2015 | 770 | 0.110 |
Why?
|
Neck Pain | 1 | 2013 | 179 | 0.100 |
Why?
|
Neck Injuries | 1 | 2013 | 152 | 0.100 |
Why?
|
Eye Infections | 1 | 2012 | 64 | 0.100 |
Why?
|
Michigan | 1 | 2013 | 350 | 0.100 |
Why?
|
Ischemia | 3 | 2023 | 1911 | 0.100 |
Why?
|
Sulfur Hexafluoride | 1 | 2011 | 25 | 0.100 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 264 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 1009 | 0.100 |
Why?
|
Trochlear Nerve | 1 | 1991 | 25 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 379 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2739 | 0.100 |
Why?
|
Tachyphylaxis | 1 | 2011 | 51 | 0.100 |
Why?
|
Mass Casualty Incidents | 1 | 2014 | 181 | 0.100 |
Why?
|
Pupil Disorders | 1 | 1991 | 33 | 0.100 |
Why?
|
Listeriosis | 1 | 1992 | 149 | 0.100 |
Why?
|
Fourier Analysis | 1 | 2012 | 447 | 0.100 |
Why?
|
Rupture | 1 | 2013 | 430 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1583 | 0.100 |
Why?
|
Catheterization | 1 | 2017 | 1468 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3528 | 0.100 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 824 | 0.100 |
Why?
|
Infrared Rays | 1 | 2012 | 249 | 0.100 |
Why?
|
Prolapse | 1 | 2010 | 68 | 0.100 |
Why?
|
Wet Macular Degeneration | 1 | 2013 | 146 | 0.100 |
Why?
|
Dexamethasone | 1 | 2018 | 1949 | 0.100 |
Why?
|
Polypropylenes | 1 | 2010 | 63 | 0.100 |
Why?
|
Serotyping | 1 | 2011 | 338 | 0.090 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2861 | 0.090 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 256 | 0.090 |
Why?
|
Copper | 1 | 2013 | 366 | 0.090 |
Why?
|
Brain Abscess | 1 | 2011 | 118 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1970 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2013 | 1849 | 0.090 |
Why?
|
Paralysis | 1 | 1991 | 249 | 0.090 |
Why?
|
Oculomotor Muscles | 1 | 1993 | 371 | 0.090 |
Why?
|
Disease Progression | 4 | 2015 | 13256 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2016 | 804 | 0.090 |
Why?
|
Mesencephalon | 1 | 1991 | 327 | 0.090 |
Why?
|
Cell Proliferation | 5 | 2019 | 10472 | 0.090 |
Why?
|
Arthritis | 1 | 2015 | 658 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2014 | 786 | 0.090 |
Why?
|
Nephritis, Hereditary | 1 | 2009 | 87 | 0.090 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 623 | 0.080 |
Why?
|
Rabbits | 2 | 2020 | 4886 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 765 | 0.080 |
Why?
|
Fibrosis | 3 | 2019 | 2026 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 852 | 0.080 |
Why?
|
Eye Diseases, Hereditary | 1 | 2009 | 117 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 24913 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1768 | 0.080 |
Why?
|
Child | 9 | 2019 | 77478 | 0.080 |
Why?
|
Acute Disease | 4 | 2012 | 7141 | 0.080 |
Why?
|
Scotoma | 1 | 2009 | 139 | 0.080 |
Why?
|
Nanoparticles | 1 | 2019 | 1902 | 0.080 |
Why?
|
Emergency Medical Services | 2 | 2021 | 1914 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1294 | 0.070 |
Why?
|
Endocarditis, Bacterial | 1 | 2011 | 453 | 0.070 |
Why?
|
Astrocytoma | 1 | 1991 | 789 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1675 | 0.070 |
Why?
|
Functional Laterality | 2 | 2011 | 2290 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4029 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 453 | 0.070 |
Why?
|
Retinopathy of Prematurity | 2 | 2005 | 421 | 0.070 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 605 | 0.070 |
Why?
|
Medicine | 1 | 2014 | 941 | 0.070 |
Why?
|
Headache | 1 | 2013 | 1219 | 0.070 |
Why?
|
Paclitaxel | 1 | 2013 | 1707 | 0.070 |
Why?
|
Apoptosis | 2 | 2019 | 9715 | 0.070 |
Why?
|
Infant | 5 | 2018 | 35070 | 0.070 |
Why?
|
Video Recording | 1 | 2010 | 944 | 0.070 |
Why?
|
Clinical Competence | 1 | 2021 | 4681 | 0.060 |
Why?
|
Fungemia | 1 | 2005 | 53 | 0.060 |
Why?
|
Conjunctiva | 1 | 2009 | 493 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3862 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 640 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1261 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19862 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2594 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1773 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4147 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2017 | 3455 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2015 | 524 | 0.060 |
Why?
|
Endothelial Growth Factors | 2 | 1997 | 694 | 0.060 |
Why?
|
Fluorouracil | 1 | 2009 | 1615 | 0.060 |
Why?
|
Streptococcus anginosus | 1 | 2023 | 24 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6756 | 0.060 |
Why?
|
Actins | 3 | 2019 | 2120 | 0.060 |
Why?
|
Epistaxis | 1 | 2004 | 111 | 0.060 |
Why?
|
Lymphokines | 2 | 1997 | 949 | 0.060 |
Why?
|
Phenylephrine | 1 | 2004 | 301 | 0.060 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2004 | 177 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1402 | 0.060 |
Why?
|
Ciliary Body | 2 | 2021 | 172 | 0.060 |
Why?
|
Single-Blind Method | 2 | 2018 | 1589 | 0.060 |
Why?
|
Pancreatitis, Chronic | 1 | 2006 | 285 | 0.050 |
Why?
|
Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6534 | 0.050 |
Why?
|
Microelectrodes | 2 | 2015 | 303 | 0.050 |
Why?
|
Panuveitis | 1 | 2002 | 32 | 0.050 |
Why?
|
Hypergammaglobulinemia | 1 | 2002 | 74 | 0.050 |
Why?
|
Survival Rate | 1 | 2017 | 12773 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2003 | 313 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12071 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3211 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 66 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1484 | 0.050 |
Why?
|
Blood Viscosity | 1 | 2002 | 124 | 0.050 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2004 | 189 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
United States | 4 | 2021 | 69693 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2005 | 705 | 0.050 |
Why?
|
Nitrous Oxide | 1 | 2002 | 177 | 0.050 |
Why?
|
Ectodermal Dysplasia | 1 | 2002 | 103 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2002 | 212 | 0.050 |
Why?
|
Debridement | 1 | 2003 | 492 | 0.050 |
Why?
|
Epithelium, Corneal | 1 | 2003 | 241 | 0.050 |
Why?
|
Remission, Spontaneous | 1 | 2001 | 380 | 0.050 |
Why?
|
Phlebotomy | 1 | 2001 | 142 | 0.050 |
Why?
|
Cell Separation | 2 | 2017 | 1749 | 0.050 |
Why?
|
Pigmentation | 1 | 2021 | 148 | 0.050 |
Why?
|
Heart Septal Defects | 1 | 2001 | 192 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18006 | 0.040 |
Why?
|
Hematocrit | 1 | 2001 | 636 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2017 | 428 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2023 | 2633 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11695 | 0.040 |
Why?
|
Neuroglia | 2 | 2011 | 925 | 0.040 |
Why?
|
Eye | 1 | 2023 | 728 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2000 | 280 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2022 | 2049 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 682 | 0.040 |
Why?
|
Acrylic Resins | 1 | 1999 | 142 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4143 | 0.040 |
Why?
|
Ceftazidime | 1 | 1998 | 68 | 0.040 |
Why?
|
Polymethyl Methacrylate | 1 | 1999 | 145 | 0.040 |
Why?
|
Beclomethasone | 1 | 1997 | 38 | 0.040 |
Why?
|
Environment | 1 | 2024 | 1115 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2781 | 0.040 |
Why?
|
Oxygen | 2 | 2017 | 4169 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1997 | 599 | 0.040 |
Why?
|
Keratins | 1 | 2019 | 515 | 0.040 |
Why?
|
Anesthetics, Inhalation | 1 | 2002 | 571 | 0.040 |
Why?
|
Candidiasis | 1 | 2000 | 365 | 0.040 |
Why?
|
Dependovirus | 1 | 2022 | 706 | 0.040 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 1997 | 101 | 0.040 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2018 | 204 | 0.040 |
Why?
|
Electroretinography | 1 | 2018 | 509 | 0.040 |
Why?
|
Cephalosporins | 1 | 1998 | 203 | 0.040 |
Why?
|
Bronchitis | 1 | 1997 | 201 | 0.040 |
Why?
|
Candida albicans | 1 | 2000 | 394 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11363 | 0.040 |
Why?
|
Albuterol | 1 | 1997 | 208 | 0.040 |
Why?
|
Betamethasone | 1 | 1995 | 45 | 0.030 |
Why?
|
Androstadienes | 1 | 1997 | 346 | 0.030 |
Why?
|
Eye Abnormalities | 1 | 1998 | 246 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2002 | 1164 | 0.030 |
Why?
|
Angiopoietin-1 | 1 | 2015 | 114 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2900 | 0.030 |
Why?
|
Cell Movement | 2 | 2017 | 5212 | 0.030 |
Why?
|
Drainage | 1 | 2020 | 1140 | 0.030 |
Why?
|
Visual Perception | 2 | 2012 | 1417 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1998 | 475 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1104 | 0.030 |
Why?
|
Blister | 1 | 2015 | 85 | 0.030 |
Why?
|
Reading | 1 | 2018 | 557 | 0.030 |
Why?
|
Chronic Disease | 3 | 2014 | 9144 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8455 | 0.030 |
Why?
|
Foscarnet | 1 | 2013 | 38 | 0.030 |
Why?
|
Bombs | 1 | 2014 | 72 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 496 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13655 | 0.030 |
Why?
|
Uveitis, Posterior | 1 | 2013 | 44 | 0.030 |
Why?
|
Glaucoma Drainage Implants | 1 | 2015 | 116 | 0.030 |
Why?
|
Optic Nerve | 1 | 1997 | 548 | 0.030 |
Why?
|
Texas | 1 | 2014 | 392 | 0.030 |
Why?
|
Social Support | 1 | 2023 | 2117 | 0.030 |
Why?
|
Suppuration | 1 | 1992 | 56 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 849 | 0.030 |
Why?
|
Optic Atrophy | 1 | 1993 | 79 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 259 | 0.030 |
Why?
|
Perioperative Period | 1 | 2014 | 256 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 1995 | 502 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3582 | 0.030 |
Why?
|
Keratin-8 | 1 | 2011 | 11 | 0.030 |
Why?
|
Visual Fields | 1 | 2018 | 1049 | 0.030 |
Why?
|
Chickenpox | 1 | 1992 | 131 | 0.030 |
Why?
|
Scleritis | 1 | 1992 | 100 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1995 | 463 | 0.020 |
Why?
|
Keratin-18 | 1 | 2011 | 38 | 0.020 |
Why?
|
Corneal Stroma | 1 | 1992 | 170 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3164 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1327 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 1991 | 112 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2006 | 3497 | 0.020 |
Why?
|
Hypertrophy | 1 | 2012 | 568 | 0.020 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 250 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5062 | 0.020 |
Why?
|
Sensory Thresholds | 1 | 2012 | 394 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1998 | 1416 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 1991 | 8829 | 0.020 |
Why?
|
Rhinitis | 1 | 1997 | 691 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 16678 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1670 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2615 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18355 | 0.020 |
Why?
|
Pedigree | 2 | 1998 | 4646 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2009 | 211 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1643 | 0.020 |
Why?
|
Pregnancy | 2 | 2016 | 29087 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2013 | 730 | 0.020 |
Why?
|
Keratitis | 1 | 1992 | 268 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 604 | 0.020 |
Why?
|
Prevalence | 2 | 2023 | 15194 | 0.020 |
Why?
|
Pain | 2 | 2019 | 4961 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2023 | 25575 | 0.020 |
Why?
|
Hyperpigmentation | 1 | 2009 | 112 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3123 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2557 | 0.020 |
Why?
|
Orientation | 1 | 2009 | 327 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 751 | 0.020 |
Why?
|
DNA, Viral | 1 | 2013 | 2224 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 383 | 0.020 |
Why?
|
Animals | 3 | 2020 | 168561 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2002 | 3695 | 0.020 |
Why?
|
Locomotion | 1 | 2009 | 378 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4229 | 0.020 |
Why?
|
Amylases | 1 | 2006 | 172 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4414 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1997 | 772 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1661 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4391 | 0.020 |
Why?
|
Lubrication | 1 | 2003 | 19 | 0.020 |
Why?
|
Syndrome | 2 | 2002 | 3248 | 0.010 |
Why?
|
Lipase | 1 | 2006 | 315 | 0.010 |
Why?
|
Reoperation | 1 | 1993 | 4200 | 0.010 |
Why?
|
Corneal Edema | 1 | 2003 | 52 | 0.010 |
Why?
|
Immunoenzyme Techniques | 2 | 1997 | 1799 | 0.010 |
Why?
|
Viscosity | 1 | 2003 | 328 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10578 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16331 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 504 | 0.010 |
Why?
|
Tropanes | 1 | 2002 | 51 | 0.010 |
Why?
|
Retinitis | 1 | 2002 | 35 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2004 | 446 | 0.010 |
Why?
|
Parasympatholytics | 1 | 2002 | 91 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 389 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1359 | 0.010 |
Why?
|
Ophthalmic Artery | 1 | 2002 | 60 | 0.010 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2005 | 406 | 0.010 |
Why?
|
Photophobia | 1 | 2002 | 67 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13029 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 847 | 0.010 |
Why?
|
Papilledema | 1 | 2002 | 118 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9305 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 2978 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9581 | 0.010 |
Why?
|
Methylprednisolone | 1 | 2002 | 388 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2016 | 3428 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40450 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19223 | 0.010 |
Why?
|
Asthma | 1 | 1997 | 5955 | 0.010 |
Why?
|
Pancreatitis | 1 | 2006 | 1090 | 0.010 |
Why?
|
Vasculitis | 1 | 2002 | 521 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2271 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1999 | 458 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11470 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1999 | 962 | 0.010 |
Why?
|
Birth Weight | 1 | 2005 | 2068 | 0.010 |
Why?
|
Membranes | 1 | 1996 | 173 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3490 | 0.010 |
Why?
|
Vimentin | 1 | 1997 | 261 | 0.010 |
Why?
|
Light Coagulation | 1 | 1995 | 72 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10392 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2479 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1092 | 0.010 |
Why?
|
Factor VIII | 1 | 1997 | 348 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2043 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 12730 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 1999 | 1440 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 1999 | 854 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1995 | 965 | 0.010 |
Why?
|
Lens Subluxation | 1 | 1991 | 20 | 0.010 |
Why?
|
Herpesvirus 3, Human | 1 | 1992 | 204 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81045 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1995 | 13921 | 0.000 |
Why?
|